Skip to content

Clinical study on the treatment of secondary lower extremity lymphedema associated with gynecological malignant tumor by pricking collaterals and cupping therapy

Clinical study on the treatment of secondary lower extremity lymphedema associated with gynecological malignant tumor by pricking collaterals and cupping therapy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050925
Enrollment
Unknown
Registered
2021-09-08
Start date
2021-09-07
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary lower limb lymphedema

Interventions

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed gynecological malignancy, concurrent pelvic lymph node dissection or radiotherapy; 2. The patient has swelling of the lower extremities and is in line with the lymphedema stage I-III; 3. Aged 20-70 years, able to cooperate to complete functional exercise; 4. The patient is willing to cooperate with the treatment follow-up and sign the informed consent; 5. No serious heart, liver and kidney function disorders; 6. No local ulceration of the affected limb.

Exclusion criteria

Exclusion criteria: 1. Combined with severe organ dysfunction such as hypoalbuminemia, nephrotic syndrome, left heart failure, etc., resulting in lower extremity edema; 2. Patients with extremity combined with cellulitis and lower extremity venous thrombosis; 3. Those who cannot tolerate cupping, acupuncture or fainting; 4. The patient's lower extremity skin infection and ulceration.

Design outcomes

Primary

MeasureTime frame
Efficacy evaluation;Circumference of affected limb;

Secondary

MeasureTime frame
Quality of life;Health economics indicators;

Countries

China

Contacts

Public ContactZhu Xiujun

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

zhuxiujun12@126.com+86 13570557432

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026